Transperineal palladium 103 prostate brachytherapy: analysis of morbidity and seed migration.

OBJECTIVES To evaluate the early morbidity of palladium 103 (103Pd) prostate brachytherapy. METHODS Thirty-two patients with Stage A or B prostate carcinoma were implanted transperineally with 103Pd using transrectal ultrasound and fluoroscopy between May 1990 and December 1992. Patients were subsequently followed to evaluate for morbidity and possibility of migration of the implanted seeds into the lungs. RESULTS The median follow-up time was 20 months (range, 2 to 45 months). The major acute toxicity of the procedure, dysuria, was seen in 88% of the patients. Although this was generally grade 1 or 2 and transient, grade 3 or 4 toxicity occurred in 18% of patients. Mild rectal symptoms (transient diarrhea, rectal bleeding) occurred in 19% of patients. Sexual functions could not be evaluated. Seven of the 3213 total seeds implanted (0.2%) were found to have migrated to the lung in 6 of 30 (20%) patients having a postoperative chest radiograph. This did not cause any clinical problems. CONCLUSIONS 103Pd prostate brachytherapy is generally associated with only mild or moderate urinary and rectal symptoms, and the incidence of severe complications is low. Further follow-up is required to evaluate the efficacy.

[1]  K. Wallner Iodine 125 brachytherapy for early stage prostate cancer: new techniques may achieve better results. , 1991, Oncology.

[2]  O. Nishizawa,et al.  [Transurethral intracavitary irradiation for carcinoma of the prostate]. , 1991, Nihon Hinyokika Gakkai zasshi. The japanese journal of urology.

[3]  L. Blank,et al.  Treatment of localized prostatic carcinoma using the transrectal ultrasound guided transperineal implantation technique. , 1992, European urology.

[4]  A. van't Riet,et al.  Ultrasonically guided transperineal seed implantation of the prostate: modification of the technique and qualitative assessment of implants. , 1992, International journal of radiation oncology, biology, physics.

[5]  W. Whitmore Conservative approaches to the management of localized prostatic cancer , 1993, Cancer.

[6]  S. Nag Radioactive iodine‐125 implantation for cancer of the prostate , 1985, The Prostate.

[7]  J. Blasko,et al.  Transperineal ultrasound-guided implantation of the prostate: morbidity and complications. , 1991, Scandinavian journal of urology and nephrology. Supplementum.

[8]  S Huttner,et al.  [A rare route for the loss of a 125-iodine seed after the interstitial therapy of prostatic carcinoma]. , 1992, Der Urologe. Ausg. A.

[9]  Permanent interstitial implantation using palladium-103: the New York Medical College preliminary experience. , 1992, International journal of radiation oncology, biology, physics.

[10]  J Roy,et al.  Treatment-related symptoms during the first year following transperineal 125I prostate implantation. , 1994, International journal of radiation oncology, biology, physics.

[11]  P. Kumar,et al.  Transperineal 125Iodine Endocurietherapy of Prostate Cancer , 1988, American Journal of Clinical Oncology.

[12]  P. Scardino,et al.  The prognostic significance of post-irradiation biopsy results in patients with prostatic cancer. , 1986, The Journal of urology.

[13]  J. Payne,et al.  Improved technique for prostate seed implantation: combined ultrasound and fluoroscopic guidance , 1992 .

[14]  M Wannenmacher,et al.  [A rare complication of interstitial therapy with iodine-125 seeds: embolization of a seed into the lung]. , 1988, Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al].

[15]  S. Kandzari,et al.  Postradiation biopsy and histological effects in early‐stage prostatic cancer treated with 125iodine implants , 1986, The Prostate.

[16]  P. Schellhammer,et al.  Prostate biopsy after definitive treatment by interstitial 125iodine implant or external beam radiation therapy. , 1987, The Journal of urology.

[17]  J Roy,et al.  Short-term morbidity from CT-planned transperineal I-125 prostate implants. , 1993, International journal of radiation oncology, biology, physics.

[18]  S. Brosman,et al.  Transrectal ultrasound-guidedinterstitial radiation therapy for localized prostate cancer , 1991 .

[19]  Blasko,et al.  Brachytherapy and Organ Preservation in the Management of Carcinoma of the Prostate. , 1993, Seminars in radiation oncology.

[20]  M Wannenmacher,et al.  Seed loss in interstitial radiotherapy of prostatic carcinoma with I-125. , 1988, International journal of radiation oncology, biology, physics.

[21]  J Roy,et al.  An improved method for computerized tomography-planned transperineal 125iodine prostate implants. , 1991, The Journal of urology.

[22]  L L Anderson,et al.  A nomograph for permanent implants of palladium-103 seeds. , 1993, International journal of radiation oncology, biology, physics.